<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03442868</url>
  </required_header>
  <id_info>
    <org_study_id>19219</org_study_id>
    <nct_id>NCT03442868</nct_id>
  </id_info>
  <brief_title>Non-invasive Brain Stimulation (NIBS) and Dual-task Walking After Stroke</brief_title>
  <official_title>Efficacy of Non-Invasive Brain Stimulation on Dual-Task Walking After Stroke: A Repetitive Transcranial Magnetic Stimulation (rTMS) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Woman's University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas Woman's University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to identify neural locus critical for dual-task walking (walking and talking)&#xD;
      in individuals with stroke. To achieve this aim, the investigators apply repetitive&#xD;
      transcranial magnetic stimulation (rTMS) to different parts of the brain and evaluate the&#xD;
      effects of brain stimulation on dual-task walking speed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will enroll 12 individuals with a stroke at least 6 months ago. Participants will&#xD;
      be tested across 3 sessions and each session will be approximately 1 week apart from each&#xD;
      other. During testing, participants will be asked to walk under two conditions: single- and&#xD;
      dual-task conditions. Under the single-task condition, participants walk on a instrumented&#xD;
      mat such that their gait performance will be captured. Under the dual-task condition,&#xD;
      participants walk on the mat while performing a counting backward task. The walking&#xD;
      assessment is followed by a 12 minute non-invasive brain stimulation using high frequency&#xD;
      rTMS. Another walking assessment will be conducted right after the brain stimulation session.&#xD;
      High frequency rTMS will be applied to different neural loci, namely primary motor cortex&#xD;
      (M1), supplementary motor area (SMA), and dorsolateral prefrontal cortex (DLPFC). The walking&#xD;
      speed under two different conditions will be compared before and after brain stimulation to&#xD;
      different neural loci.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 19, 2016</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Gait Speed</measure>
    <time_frame>before and 10 minutes after the non-invasive brain stimulation</time_frame>
    <description>gait speed in m/s will be captured using GaitRite gait assessment walkway</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Step Lengths</measure>
    <time_frame>before and 10 minutes after the non-invasive brain stimulation</time_frame>
    <description>Step lengths in centimeter (cm) will be captured using GaitRite gait assessment walkway</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Single Support Times</measure>
    <time_frame>before and 10 minutes after the non-invasive brain stimulation</time_frame>
    <description>Single support times (in % of gait cycle) will be captured using GaitRite gait assessment walkway</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Counting Task Performance</measure>
    <time_frame>before and 10 minutes after the non-invasive brain stimulation</time_frame>
    <description>number of correct responses in counting backward task</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>High frequency rTMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High frequency rTMS will be applied to different neural loci based on the randomized sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>high frequency rTMS</intervention_name>
    <description>Participants receive 16 minutes (5Hz, 24 10-second trains with a inter-train interval of 30s) of high frequency rTMS applied to either primary motor cortex (M1), supplementary motor area (SMA) and dorsolateral prefrontal cortex (DLPFC) at different sessions. Walking performance is evaluated before and after the brain stimulation.</description>
    <arm_group_label>High frequency rTMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age above 18 years&#xD;
&#xD;
          2. Diagnosis of Left hemispheric stroke at least 6 months ago&#xD;
&#xD;
          3. First time stroke OR complete gait recovery from prior stroke&#xD;
&#xD;
          4. Able to walk independently for at least 10 meters with or without walking aids&#xD;
&#xD;
          5. Have at least minimal movements (&gt; 5 degree of motion) at the affected ankle&#xD;
&#xD;
          6. Score &gt; 26 on Mini Mental State Exam (MMSE)&#xD;
&#xD;
          7. Ability to participate in the informed consent process&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Diagnosis of other neurological conditions, such as Parkinson Disease, Alzheimer,&#xD;
             Spinal Cord Injury, Multiple Sclerosis&#xD;
&#xD;
          2. Other comorbidities which could interfere with gait (i.e. amputation, severe&#xD;
             osteoarthritis)&#xD;
&#xD;
          3. Unstable clinical conditions&#xD;
&#xD;
          4. Non-ambulatory prior to onset of stroke&#xD;
&#xD;
          5. History of significant head trauma&#xD;
&#xD;
          6. Electrical, magnetic, or mechanical implantation: cardiac pacemakers or intracerebral&#xD;
             vascular clip&#xD;
&#xD;
          7. Metal implantation in the oral cavity, head/neck area and lower extremity&#xD;
&#xD;
          8. Pregnancy&#xD;
&#xD;
          9. History of seizures or unexplained loss of consciousness&#xD;
&#xD;
         10. Immediate family member with epilepsy&#xD;
&#xD;
         11. Use of seizure threshold lowering medicine&#xD;
&#xD;
         12. Current abuse of alcohol or drugs&#xD;
&#xD;
         13. Anticipated inability to complete the study&#xD;
&#xD;
         14. History of psychiatric illness requiring medication control&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hui-Ting Goh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Woman's University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Texas Woman's University</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>February 9, 2018</study_first_submitted>
  <study_first_submitted_qc>February 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 22, 2018</study_first_posted>
  <results_first_submitted>October 6, 2020</results_first_submitted>
  <results_first_submitted_qc>November 19, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 20, 2020</results_first_posted>
  <last_update_submitted>November 19, 2020</last_update_submitted>
  <last_update_submitted_qc>November 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas Woman's University</investigator_affiliation>
    <investigator_full_name>Hui Ting Goh</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 19, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/68/NCT03442868/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from Dallas Fort Worth metro area. Recruitment started in October 2016 and last participant was enrolled in Oct 2018.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS)</title>
          <description>High frequency rTMS will be applied to different neural loci based on the randomized sessions.&#xD;
high frequency rTMS: Participants receive 16 minutes (5Hz, 24 10-second trains with a inter-train interval of 30s) of high frequency rTMS applied to either primary motor cortex, supplementary motor areas and dorsolateral prefrontal cortex at different sessions. Walking performance is evaluated before and after the brain stimulation.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>High Frequency rTMS</title>
          <description>High frequency rTMS will be applied to different neural loci based on the randomized sessions.&#xD;
high frequency rTMS: Participants receive 16 minutes (5Hz, 24 10-second trains with a inter-train interval of 30s) of high frequency rTMS applied to either primary motor cortex, supplementary motor areas and dorsolateral prefrontal cortex at different sessions. Walking performance is evaluated before and after the brain stimulation.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.7" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Gait Speed</title>
        <description>gait speed in m/s will be captured using GaitRite gait assessment walkway</description>
        <time_frame>before and 10 minutes after the non-invasive brain stimulation</time_frame>
        <population>Changes in gait speed under the dual-task conditions were compared across the 3 visits.</population>
        <group_list>
          <group group_id="O1">
            <title>High Frequency rTMS</title>
            <description>High frequency rTMS will be applied to different neural loci based on the randomized sessions.&#xD;
high frequency rTMS: Participants receive 16 minutes (5Hz, 24 10-second trains with a inter-train interval of 30s) of high frequency rTMS applied to either primary motor cortex, supplementary motor areas and dorsolateral prefrontal cortex at different sessions. Walking performance is evaluated before and after the brain stimulation.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Gait Speed</title>
          <description>gait speed in m/s will be captured using GaitRite gait assessment walkway</description>
          <population>Changes in gait speed under the dual-task conditions were compared across the 3 visits.</population>
          <units>m/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Primary motor cortex (M1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.49" spread="1.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Supplementary motor area (SMA)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.80" spread="2.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dorsolateral prefrontal cortex (DLPFC)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.49" spread="2.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Step Lengths</title>
        <description>Step lengths in centimeter (cm) will be captured using GaitRite gait assessment walkway</description>
        <time_frame>before and 10 minutes after the non-invasive brain stimulation</time_frame>
        <population>Changes in right (R) and left (L) step lengths after repetitive transcranial magnetic stimulation (rTMS) applied to dorsolateral prefrontal cortex (DLPFC)</population>
        <group_list>
          <group group_id="O1">
            <title>High Frequency rTMS</title>
            <description>High frequency rTMS will be applied to different neural loci based on the randomized sessions.&#xD;
high frequency rTMS: Participants receive 16 minutes (5Hz, 24 10-second trains with a inter-train interval of 30s) of high frequency rTMS applied to either primary motor cortex, supplementary motor areas and dorsolateral prefrontal cortex at different sessions. Walking performance is evaluated before and after the brain stimulation.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Step Lengths</title>
          <description>Step lengths in centimeter (cm) will be captured using GaitRite gait assessment walkway</description>
          <population>Changes in right (R) and left (L) step lengths after repetitive transcranial magnetic stimulation (rTMS) applied to dorsolateral prefrontal cortex (DLPFC)</population>
          <units>centimeter (cm)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Changes in R step length after rTMS to DLPFC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.24" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Changes in L step length after rTMS to DLPFC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.38" spread="1.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Single Support Times</title>
        <description>Single support times (in % of gait cycle) will be captured using GaitRite gait assessment walkway</description>
        <time_frame>before and 10 minutes after the non-invasive brain stimulation</time_frame>
        <population>Changes in right (R) and left (L) single support time after repetitive transcranial magnetic stimulation (rTMS) applied to dorsolateral prefrontal cortex (DLPFC)</population>
        <group_list>
          <group group_id="O1">
            <title>High Frequency rTMS</title>
            <description>High frequency rTMS will be applied to different neural loci based on the randomized sessions.&#xD;
high frequency rTMS: Participants receive 16 minutes (5Hz, 24 10-second trains with a inter-train interval of 30s) of high frequency rTMS applied to either primary motor cortex, supplementary motor areas and dorsolateral prefrontal cortex at different sessions. Walking performance is evaluated before and after the brain stimulation.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Single Support Times</title>
          <description>Single support times (in % of gait cycle) will be captured using GaitRite gait assessment walkway</description>
          <population>Changes in right (R) and left (L) single support time after repetitive transcranial magnetic stimulation (rTMS) applied to dorsolateral prefrontal cortex (DLPFC)</population>
          <units>percentage of gait cycle</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>changes in R single support after rTMS to DLPFC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.63" spread="1.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>changes in L single support after rTMS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.50" spread="1.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Counting Task Performance</title>
        <description>number of correct responses in counting backward task</description>
        <time_frame>before and 10 minutes after the non-invasive brain stimulation</time_frame>
        <population>number of correct response under the dual-task conditions before and after the rTMS</population>
        <group_list>
          <group group_id="O1">
            <title>High Frequency rTMS</title>
            <description>High frequency rTMS will be applied to different neural loci based on the randomized sessions.&#xD;
high frequency rTMS: Participants receive 16 minutes (5Hz, 24 10-second trains with a inter-train interval of 30s) of high frequency rTMS applied to either primary motor cortex, supplementary motor areas and dorsolateral prefrontal cortex at different sessions. Walking performance is evaluated before and after the brain stimulation.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Counting Task Performance</title>
          <description>number of correct responses in counting backward task</description>
          <population>number of correct response under the dual-task conditions before and after the rTMS</population>
          <units>number of correct responses</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Primary motor cortex (M1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.18" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Supplementary motor area (SMA)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.59" spread="0.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dorsolateral prefrontal cortex (DLPFC)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.65" spread="0.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>High Frequency rTMS</title>
          <description>High frequency rTMS will be applied to different neural loci based on the randomized sessions.&#xD;
high frequency rTMS: Participants receive 16 minutes (5Hz, 24 10-second trains with a inter-train interval of 30s) of high frequency rTMS applied to either primary motor cortex, supplementary motor areas and dorsolateral prefrontal cortex at different sessions. Walking performance is evaluated before and after the brain stimulation.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <description>1 participant reported mild headache after stimulation. The headache was resolved about 2 hours after the session ended.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <description>1 participant was admitted to the hospital between the1st and the 2nd visit due to a lung infection.&#xD;
The event was deemed unrelated to the study.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Hui-Ting Goh</name_or_title>
      <organization>Texas Woman's University</organization>
      <phone>2146897723</phone>
      <email>HGoh1@twu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

